DJIA 18,203.37 -85.26 -0.47%
NASDAQ 4,979.90 -28.20 -0.56%
S&P 500 2,107.78 -9.61 -0.45%
market minute promo

Novo Nordisk (NYSE: NVO)

47.22 -0.29 (-0.61%)

REAL-TIME: Last trade at

Extended Hours: $47.21 -$0.01 (-0.02%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

NVO $47.22 -0.61%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.59
Previous Close $47.51
Daily Range $46.89 - $47.59
52-Week Range $41.72 - $49.11
Market Cap $125.1B
P/E Ratio 0.00
Dividend (Yield) $0.76 (1.2%)
Ex-Dividend Date
Dividend Pay Date
03/19/15
03/31/15
Volume 2,023,167
Average Daily Volume 1,465,464
Current FY EPS $1.87

Sector

Healthcare

Industry

Drug Makers

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary

Arena Pharmaceuticals, Inc. Earnings: Explaining the Wonky Trends

A fourth-quarter slowdown and relatively flat sales over the year.

Vivus - Flat Qsymia Scripts Point To Needed Shift

MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter

3 Stocks Driving The Health Care Sector Higher

Are Sellers Wrong to Be Short MannKind Corp.?

MannKind Corporation's short interest has soared to more than 80 million shares.

Why Vivus Inc Plummeted Today

Vivus Inc shares tanked today following results that failed to impress.

Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog

Arena: Belviq Sales Show Modest Gain - Time To Assess 2015 Expectations?

Capturing The Growth Of The Diabetic Epidemic Via Shares Of Novo Nordisk

Technology Sector Update for 02/23/2015: NVO, TSM

See More NVO News...

NVO's Top Competitors

NVO $47.22 (-0.61%)
Current stock: NVO
JNJ $102.34 (-0.85%)
Current stock: JNJ
NVS $99.06 (-1.01%)
Current stock: NVS
RHHBY $34.35 (1.07%)
Current stock: RHHBY